Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

Abstract Aims We aimed to assess the impact of pre‐admission beta‐blocker (BB) therapy on the clinical characteristics, in‐hospital treatment and outcomes of patients with cardiogenic shock (CS). Methods All patients enrolled in the multicentre prospective Altshock‐2 registry since March 2020 with a...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, Altshock‐2 investigators
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Oxford University Press 2025-08-01
Serie:	ESC Heart Failure
Ämnen:	Cardiogenic shock beta‐blockers inotropes mortality vasopressors
Länkar:	https://doi.org/10.1002/ehf2.15322
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!